...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Some twitter chatter...

Looks like we might be attracting some interest from the scientific community....let's see if I can paste this:

  1. Epigenetics Experts Retweeted Resverlogix Corp.

    A BET inhibitor specific for BRD2, in PhaseIII clinical trial for diabetics w/ high-risk cardiovascular disease. -NK

    Epigenetics Experts added,

    Resverlogix Corp. @Resverlogix_RVX
    New #Epigenetics animation - A closer look at #apabetalone https://www.youtube.com/watch?v=thkQd8KO_cE @EpigeneticsNews @Epigenetics @EpiExperts @SWReports
    2 retweets3 likes
    Reply
    Retweet
    2
    Like
    3
    More
  2. @EpiExperts @Resverlogix_RVX @EpigeneticsNews @Epigenetics @SWReports Is it really specific to BRD2 or all BETs?

    0 retweets1 like
    Reply
    Retweet
    Like
    1
    More
User Actions
Following
Resverlogix Corp.@Resverlogix_RVX

Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET protein BRD4. Thank you @SartorGreg @EpiExperts

Share
New Message
Please login to post a reply